Market Size & Trends
The global obstetrics & gynecology ultrasound devices marketsize was estimated at USD 2.13 billion in 2024 and is projected to grow at a CAGR of 4.94% from 2025 to 2030. The growth of the obstetrics & gynecology ultrasound devices industry can be attributed to the increasing prevalence of gynecological and obstetric disorders, such as uterine fibroids, ovarian cysts, and high-risk pregnancies, creating a demand for early and accurate diagnoses. Technological advancements, such as 3D/4D imaging and high-resolution image quality, improve diagnostic accuracy and visualization of fetal anatomy.
In addition, the increasing demand for advanced diagnostic technologies in women's healthcare further fuels the market's growth.
These systems allow healthcare professionals to monitor and assess the health of pregnant women, providing crucial information on fetal development, placental health, and potential complications. As awareness grows regarding the importance of early detection and prevention of gynecological and obstetric conditions, the demand for ultrasound systems with improved imaging capabilities and advanced features continues to grow. This is further supported by the increasing emphasis on prenatal care and fetal health monitoring, with ultrasound devices playing a crucial role in prenatal screenings to ensure the well-being of pregnant women.
Technological advancements in ultrasound technology significantly contribute to the growth of the OB-GYN ultrasound systems industry. Innovations such as high-resolution image quality, 3D/4D imaging, and advanced software features enhance diagnostic accuracy and provide better visualization of fetal anatomy and maternal structures. For instance, in October 2024, GE Healthcare launched the Versana Premier ultrasound system. It offers AI-enabled tools to enhance workflow, clinical efficiency, and accuracy. It's designed for diverse specialties, such as OB-GYN and cardiology, with various features, including Whizz for real-time image optimization and AI-powered labeling. The Versana Premier provides high-quality imaging and aims for simplified diagnostics. Such advancements enable more precise and detailed assessments, improving the ability to detect abnormalities and ensure appropriate treatment and management.
The obstetrics & gynecology ultrasound devices industry growth is also fueled by the increasing healthcare expenditure in developing countries, leading to the establishment of new hospitals and medical centers. For instance, in November 2024, New Mexico announced an investment of USD 5.4 million in rural health, with significant funds allocated for maternal care. Multicultural Evaluation and Consultation Associates, LLC is expected to receive USD 1.6 million to enhance maternal health coordination in Doña Ana, Curry, Lea, Chaves, Quay, and Roosevelt counties. The initiative addresses the unique challenges faced by rural communities in accessing quality healthcare. Such investment and expansion of healthcare infrastructure for maternal care creates significant opportunities for market growth.
Global Obstetrics & Gynecology Ultrasound Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global obstetrics & gynecology ultrasound devices market report based on product, portability, end use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- 2D Ultrasound
- 3D/4D Ultrasound
- Doppler Ultrasound
- Portability Outlook (Revenue, USD Million, 2018 - 2030)
- Cart/Trolley
- Portable/Handheld
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Centers
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Canada
Mexico
- Europe
Germany
France
Italy
Spain
Denmark
Sweden
Norway
- Asia Pacific
China
India
Australia
Thailand
South Korea
- Latin America
Argentina
- Middle East & Africa
Saudi Arabia
UAE
Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Portability
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Portability outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Obstetrics & Gynecology Ultrasound Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising birth rates & pregnancy monitoring needs
- 3.2.1.2. Technological advancements
- 3.2.1.3. Increasing prevalence of gynecological disorders
- 3.2.1.4. Government & private initiatives for maternal health
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of advanced ultrasound systems
- 3.2.2.2. Limited access in low-resource settings
- 3.2.2.3. Stringent regulatory approvals process
- 3.3. Obstetrics & Gynecology Ultrasound Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Obstetrics & Gynecology Ultrasound Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Obstetrics & Gynecology Ultrasound Devices Product Market Movement Analysis
- 4.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. 2D Ultrasound
- 4.4.1. 2D Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. 3D/4D Ultrasound
- 4.5.1. 3D/4D Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Doppler Ultrasound
- 4.6.1. Doppler Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Obstetrics & Gynecology Ultrasound Devices Market: Portability Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Obstetrics & Gynecology Ultrasound Devices Portability Market Movement Analysis
- 5.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by Portability, 2018 to 2030 (USD Million)
- 5.4. Cart/Trolley
- 5.4.1. Cart/trolley market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Portable/Handheld
- 5.5.1. Portable/handheld market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Obstetrics & Gynecology Ultrasound Devices Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Obstetrics & Gynecology Ultrasound Devices End Use Market Movement Analysis
- 6.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Diagnostic Centers
- 6.5.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Obstetrics & Gynecology Ultrasound Devices Market: Regional Estimates & Trend Analysis By Product, Portability, End Use
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement structure
- 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement structure
- 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement structure
- 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Competitive scenario
- 7.6.1.3. Regulatory framework
- 7.6.1.4. Reimbursement structure
- 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement structure
- 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement structure
- 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. Reimbursement structure
- 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Reimbursement structure
- 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework
- 7.6.6.4. Reimbursement structure
- 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework
- 7.6.7.4. Reimbursement structure
- 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Competitive scenario
- 7.6.8.3. Regulatory framework
- 7.6.8.4. Reimbursement structure
- 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement structure
- 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement structure
- 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement structure
- 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement structure
- 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement structure
- 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement structure
- 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement structure
- 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement structure
- 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement structure
- 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement structure
- 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement structure
- 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Competitive scenario
- 7.9.4.3. Regulatory framework
- 7.9.4.4. Reimbursement structure
- 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market share analysis, 2024
- 8.4. Company Position Analysis
- 8.5. Company Categorization (Emerging Players, Innovators and Leaders
- 8.6. Company Profiles
- 8.6.1. GE Healthcare
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Product benchmarking
- 8.6.1.4. Strategic initiatives
- 8.6.2. Siemens Healthcare Private Limited
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Product benchmarking
- 8.6.2.4. Strategic initiatives
- 8.6.3. Koninklijke Philips N.V.
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Product benchmarking
- 8.6.3.4. Strategic initiatives
- 8.6.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Product benchmarking
- 8.6.4.4. Strategic initiatives
- 8.6.5. FUJIFILM Corporation
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Product benchmarking
- 8.6.5.4. Strategic initiatives
- 8.6.6. SamsungHealthcare.com
- 8.6.6.1. Company overview
- 8.6.6.2. Financial performance
- 8.6.6.3. Product benchmarking
- 8.6.6.4. Strategic initiatives
- 8.6.7. Esaote SPA
- 8.6.7.1. Company overview
- 8.6.7.2. Financial performance
- 8.6.7.3. Product benchmarking
- 8.6.7.4. Strategic initiatives
- 8.6.8. CANON MEDICAL SYSTEMS CORPORATION
- 8.6.8.1. Company overview
- 8.6.8.2. Financial performance
- 8.6.8.3. Product benchmarking
- 8.6.8.4. Strategic initiatives
- 8.6.9. CHISON Medical Technologies Co., Ltd.
- 8.6.9.1. Company overview
- 8.6.9.2. Financial performance
- 8.6.9.3. Product benchmarking
- 8.6.9.4. Strategic initiatives
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook